The Curriculum & Faculty –The New Pathway to Professional Development for the Therapeutics Industry
Through this special collaboration between industry & academia, SeerPharma and Swinburne University are able to deliver the first university accredited graduate program in Good Manufacturing Practices, servicing the Australian and Asian Region.
The collaboration brings together two specialist providers in the education and training fields. Swinburne University has specialist expertise in higher education and research, particularly in the areas of biotechnology, product development, manufacture and environmental science SeerPharma has over 15 years experience in the provision of practical professional training in GMP, QA, GLP, Validation, GAP, GAMP and GCP.
This course is specifically designed to allow students to select from different disciplines and streams. It is presented in a structured modular format so that students can specialise in Pharmaceuticals, Biologics or Medical Devices and select subjects from all stages of the product life cycle (Pre-clinical, Clinical through to Commercial Manufacturing) and expand their skills in scientific and business electives.
Companies may use the program to provide professional development options and career pathways for their employees at all levels of the organization. The course is also ideal for students wishing to start a pharmaceutical / biotechnology career with industry recognised qualifications.
The course has been carefully designed in consultation with industry stakeholders. The Advisory board consists of representatives from:
- GlaxoSmithKline
- CSL Limited
- Therapeutic Goods Administration (TGA)
- Swinburne University
- SeerPharma Pty Ltd
- RACI
- The University Sector
- Victoria University of Technology
- Monash University
- CSIRO
- Minifab
"Sigma Pharmaceuticals recognise that in today's regulatory environment it is a business imperative that our staff are fully trained in the principles and practices of GMP and compliance. Having access to a certified GMP training program, linked to professional development, is a major initiative for the Pharmaceutical industry in Australia. I believe the industry will remain current with international best practice through the initiatives of this program."
Elmo de Alwis – Managing Director and CEO, Sigma Pharmaceuticals
This programme is unique in bringing together both the practical & proven QA & compliance experience of industry best practise with the academic structure & disciplines conferred by a leading tertiary institution.
This is a most exciting development that establishes the therapeutic industries pre-eminent qualifications in this field in the Australian & the South East Asian Region and takes professional development in Quality Assurance & Compliance to a new level.
